Life-saving medicine national heart surgery out of stock Wei Wei Planning Commission, Planning Commission said the month supply | protamine | | heart disease _ news

Original title: "protamine" national stock national sanitation Planning Commission: end of May delivery

Beijing News Alerts (reporter Li Dandan) recently, there were reports of surgery used to treat heart disease medication protamine shortages even as many foreclosures across the country. The National Health Commission responded on May 10, expected around the end of May to supply to the market.

Media reports said recent surgery as a treatment for heart disease drugs, each priced at more than 10 protamine sulfate injection (called protamine) in more than a month there is a shortage in many, many hospitals during cardiopulmonary bypass heart operation had to be suspended or delayed.

Protamine is the drug for heart surgery, should be an alternate, now only Shanghai the first biochemical pharmaceutical and pharmaceutical company, Beijing Kang Kaiyue two drug manufacturers can produce. Recently, protamine reflect tight supply as much, or even out of stock.

It is understood that the protamine Pharmacopoeia standards, Enterprise since the end of 2015 to suspend production and recalled batches of drugs from the market, leading to temporary supply shortages.

State Health Planning Commission said, protamine drugs pharmacopeia standards amendments have been completed so far, National Commission of health, food and drug administration, Ministry of industry and information technology departments are closely coordinated, and contribute to the restoration of production and supply, is expected around the end of May to supply to the market.

National Wei Planning Commission said, consider to fish fine protein in recent years to has been overall supply tension, often occurred shortage, recently, workers letter, and health family planning, and sent modified, and drug prison 4 Department goalkeeper including fish fine protein zainei of 9 a drug into has 2016 years clinical required, and dosage small, and market supply shortage drug of Sentinel production pilot work, and has Yu April 29 in national health family planning, and industrial and information Department website began public tender production enterprise.

Responsible editor: Wang Hao

Article keywords:
Yu Jingwei municipal heart disease

I want feedback
Save a Web page
The Beijing News

心脏病手术救命药全国性缺货 卫计委称月底供货|鱼精|卫计委|心脏病_新闻资讯

　　原标题：“鱼精蛋白”全国性缺货 国家卫计委：五月底可供货

　　新京报快讯(记者 李丹丹)近期，有报道称用于治疗心脏病的手术必用药鱼精蛋白在全国多地出现短缺甚至断供。国家卫生计生委5月10日下午回应称，预计5月底前后即可向市场供货。

　　有媒体报道称，近期作为治疗心脏病的手术必用药，每支售价十几元的硫酸鱼精蛋白注射液(简称鱼精蛋白)一个多月来在多地出现短缺，不少医院心脏病体外循环手术被迫暂停或者推延。

　　鱼精蛋白是开展心脏外科手术等必须备用的药品，现在只有上海第一生化药业有限公司和北京悦康凯悦制药有限公司两家药品生产企业可以生产。近期，多地反映鱼精蛋白供应紧张、甚至断货。

　　据了解，因鱼精蛋白药典标准修订，企业自2015年底暂时停产，并从市场上召回了相关批次药品，导致暂时性供应短缺。

　　国家卫计委称，目前鱼精蛋白药品药典标准修订已完成，国家卫生计生委、食品药品监管总局、工业和信息化部等部门正密切协调配合，推动恢复生产供应，预计5月底前后即可向市场供货。

　　国家卫计委表示，考虑到鱼精蛋白近些年来一直整体供货紧张，经常发生短缺，近期，工信、卫生计生、发改、药监4部门将包括鱼精蛋白在内的9个药品纳入了2016年临床必需、用量小、市场供应短缺药品的定点生产试点工作，并已于4月29日在国家卫生计生委、工业和信息化部网站开始公开招标生产企业。

责任编辑：王浩成

文章关键词：
鱼精 卫计委 心脏病

我要反馈
保存网页
新京报